Return to content in this issue

Successful Desensitization to Irinotecan After Severe Hypersensitivity Reaction

Cubero JL^1,2, Escudero P^2,3, Yubero A^2,3, Millán P⁴, Sagredo MA⁵, Colás C<sup>1,2

1</sup>Allergy Department, University Hospital Lozano Blesa of Zaragoza, Zaragoza, Spain
²Instituto de Investigación Sanitaria Aragón (IIS Aragón), Spain
³Oncology Department, University Hospital Lozano Blesa of Zaragoza, Zaragoza, Spain
⁴Intensive Care Unit, University Hospital Lozano Blesa of Zaragoza, Zaragoza, Spain
⁵Pharmacy Department, University Hospital Lozano Blesa of Zaragoza, Zaragoza, Spain

J Investig Allergol Clin Immunol 2016; Vol 26(5) : 314-316
doi: 10.18176/jiaci.0075